Skip to content

Dezocine

NERVOUS SYSTEM

Also known as: dalgan, dezocine hydrobromide

OfmFDA approvedATC N02AX03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Dezocine is an ofm drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including OPRM1 and OPRK1. Recorded indications include Pain.

  • Approval status: ofm.
  • Molecular targets: OPRM1 and OPRK1 (2 listed in DrugCentral).
  • Indications: Pain.
  • ATC code: N02AX03 (Other opioids).
  • Molecular formula: C16H23NO; molecular weight 245.37 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Pain

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Mu-type opioid receptorOPRM1partial agonistEC50 7.42
Kappa-type opioid receptorOPRK1antagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—ASTRAZENECA

ATC classification

ATC codeTherapeutic hierarchy
N02AX03NERVOUS SYSTEM › ANALGESICS › OPIOIDS › Other opioids

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Dezocine is on its molecule page.

Molecular formulaC16H23NO
Molecular weight245.37 g/mol
CAS number53648-55-8
InChIKeyVTMVHDZWSFQSQP-VBNZEHGJSA-N
PubChem CID3033053
C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C13)[C@@H]2N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Dezocine used for?

DrugCentral lists the following indications for Dezocine: Pain.

How does Dezocine work?

Its molecular targets in DrugCentral include OPRM1 (partial agonist) and OPRK1 (antagonist).

What is the chemical formula of Dezocine?

Dezocine has the molecular formula C16H23NO and a molecular weight of 245.37 g/mol.

Browse: all drugs starting with D · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets2
Indications1
FormulaC16H23NO
DrugCentral ID847
Interactive profile